RACHEL BOWLES: Open Payments
NPI 1609380237 · GAINESVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$611 in 29 payments from 12 companies in 2025. Trend: 2023 $229 · 2024 $341 · 2025 $611
Food & beverage: $611
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $184 |
| AstraZeneca Pharmaceuticals LP | 5 | $157 |
| Lilly USA, LLC | 4 | $63 |
| Novo Nordisk Inc | 2 | $44 |
| Astellas Pharma US Inc | 1 | $28 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $23 |
| OWP Pharmaceuticals, Inc. | 1 | $22 |
| Antares Pharma, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
Products named: VRAYLAR, AIRSUPRA, BREZTRI, MOUNJARO, Veozah, NEFFY, Subvenite, XYOSTED.
Industry payments across TX — which companies pay providers there.
